secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001493152-26-002057
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma director Surendra Ajjarapu resigns effective Jan 7, 2026
-------------------------------------------------------------------------

- Surendra Ajjarapu resigned as Director of Aspire Biopharma, effective January 7, 2026.
- Resignation not due to any disagreement with the Company, Board, or management.
- No replacement for the vacant director position has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226002057/0001493152-26-002057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226002057/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-002057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer